Step-wise management following the MMIDSP Typhoid Management Guidelines 2022 — Pakistan's own national society guidance, written for a setting with high antimicrobial resistance.
Any patient presenting with fever with no clear focus of infection in an endemic setting, for more than 3 days should be suspected to have typhoid fever.
Two sets of blood culture are optimal before starting antibiotic therapy, and in those patients who are already on antibiotics but not responding to therapy.
In bacteraemic patients, automated blood cultures can turn positive as early as 4 hours, with final identification and susceptibility results available in the following 48 hours.
Suspected or culture-proven enteric fever with jaundice, drowsiness, severe abdominal pain and intestinal haemorrhage, severe sepsis or septic shock.
Select the resistance category reported by the laboratory.
Strains sensitive to first-line drugs (chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole) and third-generation cephalosporins, with or without resistance to second-line drugs (fluoroquinolones).
Strains resistant to first-line drugs (ampicillin, trimethoprim-sulfamethoxazole, chloramphenicol) and/or fluoroquinolones, but sensitive to third-generation cephalosporins.
Strains resistant to all recommended antibiotics for typhoid fever (first-line, second-line and third-generation cephalosporins), but sensitive to carbapenems and azithromycin.
Strains resistant to third-generation cephalosporins but sensitive to carbapenems and azithromycin, as well as to chloramphenicol, cotrimoxazole or fluoroquinolones. MMIDSP added this category on reports of strains resistant to third-generation cephalosporins but sensitive to chloramphenicol, cotrimoxazole or fluoroquinolones.
Any patient presenting with fever with no clear focus of infection in an endemic setting, for more than 3 days, should be suspected to have typhoid fever. The guideline also requires you to rule out malaria, dengue and other causes of acute febrile illness of more than 3 days duration.
No. The MMIDSP 2022 guideline states that positive serological tests such as Widal and TyphiDOT are not recommended for the diagnosis of enteric fever and are not included in the case definitions of typhoid. It adds that serological tests should never be ordered or relied upon to diagnose or rule out enteric fever. Blood culture is the diagnostic standard.
Two sets of blood culture are optimal before starting antibiotic therapy, and also in patients already on antibiotics who are not responding. In bacteraemic patients automated cultures can turn positive as early as 4 hours, with final identification and susceptibility in the following 48 hours.
Typhoid caused by S. Typhi strains resistant to all recommended antibiotics for typhoid fever — first-line drugs, fluoroquinolones and third-generation cephalosporins — but still sensitive to carbapenems and azithromycin. This is why ceftriaxone fails in many Pakistani patients.
For a clinically stable patient, dosed by body weight: under 60 kg, a 1 g oral loading dose followed by 500 mg every 24 hours for 7–10 days; over 60 kg, 1 g every 24 hours. Paediatric dosing is 8–10 mg/kg. If the patient cannot take orally, is haemodynamically unstable, is deteriorating or develops complications, admit or refer and use a carbapenem.
Fever defervescence is prolonged in typhoid and may take 5–7 days to improve. The guideline explicitly warns not to rush to change antibiotics — monitor for improvement in the frequency and intensity of fever instead. Appetite and general condition often improve before the fever does.
Most categories require 14 days. For XDR typhoid, azithromycin is given for 7–10 days, or a carbapenem for 10–14 days with de-escalation to oral azithromycin to complete a total of 14 days. For MDR typhoid the guideline warns that shorter cephalosporin courses may lead to relapse.
The guideline states two different empiric regimens in two separate sections — azithromycin or a carbapenem in the Treatment section, and cefixime or ceftriaxone in the Management guidelines section. This tool reproduces both verbatim with their sections and does not choose between them, because in a setting with high XDR prevalence they are not equivalent. Decide based on local resistance patterns and your patient.
Despite completion of treatment, patients should be monitored for relapse or complications for 3 months after treatment has commenced.
Background reading — why ceftriaxone fails, and the one test the guideline says never to rely on: XDR typhoid in Pakistan.